Department of Anesthesiology, Faculty of Medicine, Khon Kaen University, 123 Mitrapap road, Ampur Muang, Khon Kaen, 40002, Thailand.
BMC Anesthesiol. 2021 Feb 13;21(1):50. doi: 10.1186/s12871-021-01272-2.
The Analgesia Nociception Index (ANI) has been suggested as a non-invasive guide for analgesia. Our objective was to compare the efficacy of ANI vs. standard pharmacokinetic pattern for guiding intraoperative fentanyl administration.
This was a prospective, randomized, controlled study of adult female patients undergoing elective mastectomy under general anesthesia. The patients were randomized to the ANI-guided group receiving a loading dose of 75 μg of fentanyl followed by 25 μg when the ANI score was under 50. The Control group received the same loading dose followed by 25 μg every 30 min with additional doses when there were signs of inadequate analgesia (viz., tachycardia or hypertension).
Sixty patients-30 in each group-were recruited. Although the actual mean ANI score was higher in the ANI-guided than in the Control group (mean difference 2.2; 95% CI: 0.3 to 4.0, P = 0.022), there was no difference in the primary outcome-i.e., intraoperative fentanyl consumption (mean difference - 4.2 μg; 95% CI: - 24.7 to 16.4, P = 0.686 and - 0.14 μg·kg·h; 95% CI: - 0.31 to 0.03, P = 0.105). No difference between groups was shown for either intraoperative blood pressure and heart rate, or for postoperative outcomes (i.e., pain scores, morphine consumption, or sedation scores) in the postanesthesia care unit.
Intraoperative fentanyl administration guided by ANI was equivalent to that guided by a modified pharmacologic pattern. In a surgical model of mastectomy, the ANI-guided intraoperative administration of fentanyl had no impact on clinical outcomes.
The study was registered with ClinicalTrials.gov ( NCT03716453 ) on 21/10/2018.
镇痛-伤害指数(ANI)已被提议作为一种非侵入性的镇痛指导方法。我们的目的是比较 ANI 与标准药代动力学模式在指导术中芬太尼给药方面的疗效。
这是一项前瞻性、随机、对照研究,纳入了 60 名接受全身麻醉下择期乳房切除术的成年女性患者。患者被随机分为 ANI 指导组,给予 75μg 芬太尼负荷剂量,当 ANI 评分低于 50 时给予 25μg。对照组给予相同的负荷剂量,随后每 30 分钟给予 25μg,当出现镇痛不足迹象(即心动过速或高血压)时给予额外剂量。
共纳入 60 例患者,每组 30 例。尽管 ANI 指导组的实际平均 ANI 评分高于对照组(平均差值 2.2;95%CI:0.3 至 4.0,P=0.022),但两组主要结局(即术中芬太尼消耗量)无差异(平均差值-4.2μg;95%CI:-24.7 至 16.4,P=0.686;-0.14μg·kg·h;95%CI:-0.31 至 0.03,P=0.105)。两组间术中血压和心率或术后结果(即术后疼痛评分、吗啡消耗量或镇静评分)均无差异。
根据 ANI 指导的术中芬太尼给药与根据改良药理学模式指导的给药等效。在乳房切除术的手术模型中,根据 ANI 指导的术中芬太尼给药对临床结局没有影响。
该研究于 2018 年 10 月 21 日在 ClinicalTrials.gov 注册(NCT03716453)。